<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the gene encoding the basal lamina (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) component laminin alpha2 (LAMA2) cause merosin-deficient <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> 1A (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e>), a complex disorder that includes <z:hpo ids='HP_0003429'>hypomyelination</z:hpo> and myodegeneration </plain></SENT>
<SENT sid="1" pm="."><plain>In dystrophia muscularis (dy) mice bearing Lama2 mutations, myofibers and Schwann cells fail to assemble stable <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e>, which are thought to be crucial for myofiber survival and Schwann cell differentiation </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we describe defects in a new allele of Lama2 in mice, nmf417, in which a point mutation substitutes Arg for Cys79 at a universally conserved CxxC motif in the laminin N-terminal (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) domain; this domain mediates laminin-laminin interactions </plain></SENT>
<SENT sid="3" pm="."><plain>nmf417 homozygosity caused progressive myodegeneration and severe peripheral amyelination in nerve roots, similar to previous Lama2 mutations, but without the pervasive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> thinning previously associated with the disorder </plain></SENT>
<SENT sid="4" pm="."><plain>In direct contrast to the previously characterized dy and dy2J alleles, nmf417 homozygous myofibers frequently had thickened <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Severe amyelination in nmf417-mutant nerve roots suggested complete laminin 2 inactivation for Schwann cells, although myelinated fibers had <z:mpath ids='MPATH_458'>normal</z:mpath> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The results reveal crucial roles for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> domain CxxC motif in both nerve and muscle, but challenge expected relationships between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-domain function, Ln2 activity and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> stability </plain></SENT>
<SENT sid="7" pm="."><plain>The nmf417 mutation provides a defined animal model in which to investigate mechanisms and treatments for moderate forms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> </plain></SENT>
</text></document>